Abraham Accords Cooperation: Securing Medical Supply Chains
This act establishes a new bureau within the Food and Drug Administration (FDA) to foster cooperation with Abraham Accords countries. The goal is to enhance the security of essential medical product supply chains for the United States, reducing reliance on countries with human rights concerns. Citizens may experience improved access to medicines and medical devices.
Key points
Creation of an Abraham Accords Bureau within the FDA to promote medical cooperation.
Objective: Strengthen the security of U.S. medical supply chains by collaborating with Abraham Accords countries.
Restriction on importing medical products from countries with human rights violations, potentially impacting global supply chains.
Expired
Citizen Poll